Nilotinib

Results: 37



#Item
1Pharmaceuticals and Medical Devices Agency This English version is intended to be a reference material to provide convenience for users. In the event of inconsistency between the Japanese original and this English transl

Pharmaceuticals and Medical Devices Agency This English version is intended to be a reference material to provide convenience for users. In the event of inconsistency between the Japanese original and this English transl

Add to Reading List

Source URL: www.pmda.go.jp

Language: English - Date: 2016-08-04 23:27:34
2Pharmaceuticals and Medical Devices Agency This English version is intended to be a reference material for the convenience of users. In the event of inconsistency between the Japanese original and this English translatio

Pharmaceuticals and Medical Devices Agency This English version is intended to be a reference material for the convenience of users. In the event of inconsistency between the Japanese original and this English translatio

Add to Reading List

Source URL: www.pmda.go.jp

Language: English - Date: 2016-08-04 23:27:38
3From bloodjournal.hematologylibrary.org at Dana-Farber Cancer Institute on August 23, 2011. For personal use only: Prepublished online June 8, 2011; doi:blood

From bloodjournal.hematologylibrary.org at Dana-Farber Cancer Institute on August 23, 2011. For personal use only: Prepublished online June 8, 2011; doi:blood

Add to Reading List

Source URL: michorlab.dfci.harvard.edu

Language: English - Date: 2011-08-23 09:56:20
4Microsoft Wordfile00

Microsoft Wordfile00

Add to Reading List

Source URL: michorlab.dfci.harvard.edu

Language: English - Date: 2014-10-28 13:51:00
5SPECIAL AUTHORIZATION REQUEST FOR COVERAGE OF HIGH COST CANCER DRUGS (Filgrastim, Capecitabine, Imatinib, Dasatinib, Erolotinib, Sunitinib, Pazopanib, Fludarabine, Sorafenib, Crizotinib, Tretinoin, Nilotinib, Temozolomid

SPECIAL AUTHORIZATION REQUEST FOR COVERAGE OF HIGH COST CANCER DRUGS (Filgrastim, Capecitabine, Imatinib, Dasatinib, Erolotinib, Sunitinib, Pazopanib, Fludarabine, Sorafenib, Crizotinib, Tretinoin, Nilotinib, Temozolomid

Add to Reading List

Source URL: www.gov.pe.ca

Language: English - Date: 2015-04-28 07:44:05
6Tasigna (nilotinib) Capsules Label

Tasigna (nilotinib) Capsules Label

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2010-06-17 17:36:57
    7Design, Syntheses and SAR of Inhibitors Targeting the T315I-ABL Mutation Jianguo Cao1, Kathy Barrett2, Richard M. Fine3, Colleen Gritzen1, John Hood2, Jason Kang3, Dan Lohse2, Chi Ching Mak1, Andrew McPherson1, Glenn Nor

    Design, Syntheses and SAR of Inhibitors Targeting the T315I-ABL Mutation Jianguo Cao1, Kathy Barrett2, Richard M. Fine3, Colleen Gritzen1, John Hood2, Jason Kang3, Dan Lohse2, Chi Ching Mak1, Andrew McPherson1, Glenn Nor

    Add to Reading List

    Source URL: www.biopredict.com

    Language: English - Date: 2006-11-28 17:36:48
    8HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Tasigna safely and effectively. See full prescribing information for Tasigna. Tasigna® (nilotinib) Capsules Initial

    HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Tasigna safely and effectively. See full prescribing information for Tasigna. Tasigna® (nilotinib) Capsules Initial

    Add to Reading List

    Source URL: www.accessdata.fda.gov

    Language: English - Date: 2012-05-02 15:14:28
    9Takahashi et al. Biomarker Research 2014, 2:6 http://www.biomarkerres.org/contentRESEARCH Open Access

    Takahashi et al. Biomarker Research 2014, 2:6 http://www.biomarkerres.org/contentRESEARCH Open Access

    Add to Reading List

    Source URL: www.biomarkerres.org

    Language: English
    10Honours Projects 2014 – Pharmacology Pharmacogenomics and pharmacokinetics of tyrosine kinase inhibitors in leukaemia Project Background Several pharmacogenomic studies are likely to be offered for 2013 in

    Honours Projects 2014 – Pharmacology Pharmacogenomics and pharmacokinetics of tyrosine kinase inhibitors in leukaemia Project Background Several pharmacogenomic studies are likely to be offered for 2013 in

    Add to Reading List

    Source URL: health.adelaide.edu.au

    Language: English - Date: 2013-09-25 02:05:52